ClinicalTrials.Veeva

Menu

The Effect of Low-frequency rTMS on Motor Function in PD Patients With Freezing of Gait

T

Tel Aviv Sourasky Medical Center

Status

Unknown

Conditions

Parkinson's Disease

Treatments

Device: Low-frequency repetitive Transcranial Magnetic Stimulation
Device: Sham maintenance
Device: Sham
Device: rTMS maintenance

Study type

Interventional

Funder types

Other

Identifiers

NCT02221544
TASMC-13-NG-599-CTIL

Details and patient eligibility

About

This study is a double blind comparative study examining the effectiveness of the rTMS treatment on Freezing of Gait (FOG) phenomenon in patients with Parkinson's disease. We hypothesize that treatment using rTMS stimulation on frontal lobe areas will improve gait quality and decrease the frequency of FOG in patients with Parkinson's disease.

Full description

A course of low-frequency repetitive transcranial magnetic stimulation (rTMS) delivered over the supplementary motor area (SMA) improves motor symptoms in patients with Parkinson's disease (PD).

The present study is a comparative study that examines the effectiveness of rTMS treatment technique Freezing of Gait (FOG) phenomenon in Parkinson's disease patients. We hypothesize that treatment using rTMS stimulation on frontal areas will decreasing frequency of FOGs in patients with Parkinson's disease and improve gait quality and quality of life.

Enrollment

20 estimated patients

Sex

All

Ages

50 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Idiopathic Parkinson's disease (PD), as diagnosed by a neurologist.
  2. The mini-mental state examination questionnaire score above 24 points.
  3. Suffer from a disabling phenomenon called Freezing of Gait (FoG) (Freezing Of Gait questionnaire score> = 10)
  4. Negative responses to the Preliminary Safety Magnetic Stimulation Treatment questionnaire.

Exclusion criteria

  1. Other neurological or psychiatric disorders.
  2. Severe personality disorder.
  3. High Blood Pressure.
  4. History of epilepsy, seizures or convulsions.
  5. History of epilepsy or convulsions in first-degree relatives.
  6. History of head injury or stroke.
  7. Metal remains of the skull or inside the brain (outside the oral cavity).
  8. Surgeries including metallic implants or known history of metal particles in the eye, pacemakers, hearing devices transplantation, or medical pumps.
  9. Current history of migraines for the last six months.
  10. A history of drug or alcohol abuse
  11. Other medical research in the time to experiment or three months ahead. -

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

20 participants in 2 patient groups

rTMS treatment followed by Sham
Experimental group
Description:
A course of low-frequency repetitive transcranial magnetic stimulation (rTMS) delivered over the supplementary motor area (SMA) followed by rTMS maintenance period (1 month) and followed by sham treatment in order to show the efficacy of treatment
Treatment:
Device: rTMS maintenance
Device: Sham
Device: Sham maintenance
Device: Low-frequency repetitive Transcranial Magnetic Stimulation
Sham treatment followed by rTMS
Experimental group
Description:
A course of sham followed by followed by sham maintenance period (1 month) and than followed by low-frequency repetitive transcranial magnetic stimulation (rTMS) delivered over the supplementary motor area (SMA) in order to show the effectiveness of rTMS
Treatment:
Device: rTMS maintenance
Device: Sham
Device: Sham maintenance
Device: Low-frequency repetitive Transcranial Magnetic Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Anat Mirelman, PhD; Nir Giladi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems